MRVI
Maravai LifeSciences Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.08
-0.21 ▼ -6.38%
🌙 3월 13일 6:17 PM ET (한국 3/14 07:17)
$3.08
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.91 | Insider Own | 28.83% | Shs Outstand | 0.15B | Perf Week | -13.24% |
| Market Cap | 0.79B | Forward P/E | - | EPS next Y | 18.85% | Insider Trans | 0.77% | Shs Float | 0.10B | Perf Month | -1.28% |
| Enterprise Value | 1.10B | PEG | - | EPS next Q | -0.05 | Inst Own | 76.58% | Short Float | 10.21% | Perf Quarter | -17.43% |
| Income | -0.13B | P/S | 4.26 | EPS this Y | 37.46% | Inst Trans | 0.95% | Short Ratio | 8.87 | Perf Half Y | 10.39% |
| Sales | 0.19B | P/B | 2.11 | EPS next 5Y | 24.5% | ROA | -14.7% | Short Interest | 10.64M | Perf YTD | -5.23% |
| Book/sh | 1.46 | P/C | 3.65 | EPS past 3/5Y | - | ROE | -48.64% | 52W High | -24.97% ($4.11) | Perf Year | 27.27% |
| Cash/sh | 0.84 | P/FCF | - | Sales past 3/5Y | -40.53% -8.15% | ROIC | -23.23% | 52W Low | 84.98% ($1.66) | Perf 3Y | -79.44% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 12.14% | Gross Margin | 17.01% | Volatility(W/M) | 7.89% 6.07% | Perf 5Y | -91.46% |
| Dividend TTM | - | EV/Sales | 5.92 | Sales Y/Y TTM | -28.34% | Oper. Margin | -41.84% | ATR (14) | 0.22 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.69 | EPS Q/Q | -33.41% | Profit Margin | -70.41% | RSI (14) | 38.64 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.6 | Sales Q/Q | -11.59% | SMA20 | -8.07% ($3.35) | Beta | 0.36 | Target Price | $4.33 |
| Payout | - | Debt/Eq | 1.72 | Earnings | 2000000 | SMA50 | -11.4% ($3.48) | Rel Volume | 1.43 | Prev Close | $3.29 |
| Employees | 435 | LT Debt/Eq | 1.65 | EPS/Sales Surpr. | 43.02% 1.67% | SMA200 | 2.55% ($3) | Avg Volume(3M) | 1.20M | Price | $3.08 |
| IPO | 2020/11/20 | Option/Short | Yes/Yes | Trades | 6562 | Volume | 1,713,848 | Change | -6.38% |
뉴스 로딩 중...